$PFE U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer https://www.businesswire.com/news/home/20210303006042/en/U.S.-FDA-Expands-Approval-of-Pfizer’s-LORBRENA®-as-First-Line-Treatment-for-ALK-Positive-Metastatic-Lung-Cancer